About
Technology
Issues
FAQ
Links
Official Page
2748 Assessment of associations between disease stage and toxicity with bevacizumab (BEV) in ICON7, a phase III trial of front-line carboplatin/paclitaxel (CP) ± BEV for ovarian cancer (OC)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.